Albemarle has finally started to show some signs of life over the last few months - up over 50% since August, when its CAPE ratio was at its lowest level since the Global Financial Crisis. The last three times the Shiller PE was this low, the stock saw returns of not percentages, but multiples over the next few years.
CELH is starting to look more and more interesting. Down over 70% from all-time-high earlier this year and seeing massive divergences on some major indicators. Plus, price seems to be holding at support from 2022 and 2023.
It's difficult to determine whether or not you're catching a falling knife or buying something at a discount after a steep selloff. Although ALB bulls have been on the wrong side of the market for the last few years, there is no time in the near future where lithium will not be an essential chemical. Plus, on a logged chart, ALB has recently tagged its long-term...
Crazy how irrational Mr. Market can be on his bad days. Imagine being able to take a walk down to the money store and buy a bundle of cash for 40% off. Is that what's happening with Kronos stock? Lets break it down: As of last quarter, their total assets were $182.98M and their total liabilities were $46.01M, leaving a book value of equity of $136.97M. Using...
Utility stocks have been on a tear recently. Just a few days ago, 93% of the stocks in the S&P Utilities Index were trading above their 200-day moving average, and now the breadth is deteriorating rapidly with just 80% of these constituents above their respective MAs. After today's slide, it seems the line of least resistance is to the downside, at least in the...
Albemarle is in the midst of one of its biggest retracements in history. It has only fallen this far from its all time high three times in the last thirty years and has had a massive recovery after each of these dips. Still fundamentally sound, profitable, and trading at some of its lowest multiples ever, it doesn't get much better than this.
The Japanese Yen has been crushed over the last year, but has recently bounced off its late 2022 low, almost to the exact tick. Predicting the exact price direction over the next hour or couple days is a guessing game, but for those with a timeframe of a few weeks to a few months may want to take a closer look at this one. Setups this clean don't come around...
CROX is now up over 16% MTD, after being down as much as 17%. While it certainly wouldn't have the same growth expectations as something like the tech sector, the company still seems to be fundamentally sound with pretty consistent YoY increasing revenue, along with massive profit margins and returns on equity. A short-term reversal may be in order based on...
The Bear Case There is no question that NVDA is a killer company with a monster product line. But let's not forget that there is a difference between a good product and a good investment. Valuations matter, and this company is still trading at extreme multiples of the typical metrics - P/E, P/B, P/S. Even though they've crushed earnings estimates the last two...
Although WOLF has been demolished over the last few years, it has been on a tear to the upside recently - up over 20% from its late October low, which, coincidentally was a level extremely close to its bottom in early 2020. This area should act as strong support and will likely favor the long-term bulls in this classic setup.
The market for streaming and entertainment has certainly become highly saturated, but few have as good of a setup as PARA does right now. The company is still profitable and trading well below its book value. Clean balance sheet and fundamentally attractive based on Joel Greenblatt's "Magic Formula" criteria (see MagicFormulaInvesting.com - Minimum Market Cap: ...
I doubt Zoom is in for another 800% gain, but the company is far from worthless. Still down about 90% from its all time high and trading in an area that has historically acted as support.
Medifast's stock has slid over 80% from its 2021 high, putting its major valuation metrics at levels comparable to 2008, 2011, and 2020. Despite the massive decline, the company's financial position still seems to be quite sound - big cash position, healthy current ratio, massive profit margin and return on capital. On top of that, any long-term investor is...
Albemarle has been beaten up throughout most of 2023, sliding over 60% from its historical high. After such a major decline, the Lithium monster's Price-to-book ratio is nearing a level comparable to its major lows in 2008, 2015, and 2020. For a company that also has a trailing twelve month earnings yield that is at historical highs, such a selloff seems...
Short term bearish on MCD. Just hit key resistance level matched by bearish RSI/Price divergence. I'll stay short for the time being unless it breaks out above its resistance level. This also came after a long run up, thinking of buying puts while they're cheap.
Even after beating earnings by nearly 70% ATVI has moved down and created what I think is an excellent buy. On top of their solid earnings, the 6-month normalized RSI is sitting at oversold levels about to cross above 30. Their is also bullish RSI/price divergence creating an arguably more reliable signal (marked by the blue line).
Nasdaq 100 is looking oversold after a bad week for tech. However, after a big selloff the RSI over multiple time frames shows oversold levels. On top of being below the standard 30 level, the RSI dips below the lower adjusted (50 period, 2.1 standard deviations) bollinger band for a more accurate reading of oversold. Over the past 6-months, the combination of the...
The 6-month RSI on MU is sitting at oversold levels around 30. The adjusted bollinger bands on the RSI confirm the oversold level. Price also tags the lower line on the wedge . Excellent technicals and fundamentals; extremely low P/E ratio, suitable for investors and traders. Watching for a breakout within the next few weeks.